Showing results (371-380 of 410) with videos related to

Sort By:
Pageof 41
Molecular Therapy. Oncology|March 11, 2026
Intravenous oncolytic vaccinia expressing transgenes for enhanced safety, inhibition of shedding, imaging, and systemic cancer immunotherapyLiliana Maruri-Avidal, Prajit Limsirichai, Nathaniel Gulizia, et al.
Molecular Therapy. Oncology|March 11, 2026
Outcomes of point-of-care manufactured CAR T cell therapy for B cell acute lymphoblastic leukemia and non-Hodgkin lymphoma in VietnamLiem Thanh Nguyen, Duy D Nguyen, Quoc Khanh Bach, et al.
Molecular Therapy. Oncology|March 2, 2026
The oncolytic vesicular stomatitis virus VSV-GP shows profound oncolytic activity in NUT-carcinoma cell linesRieka C Buchenau, Anne M Schiller, Julia Beil, et al.
Molecular Therapy. Oncology|April 30, 2026
Class I HDAC inhibition enhances the stem-like memory properties of CRISPR-engineered CAR T cells in neuroblastomaDan Cappabianca, Mahmoud Toulany, Seth Zima, et al.
Molecular Therapy. Oncology|May 11, 2026
AAV transduction of human glioblastoma cell lines induces perturbation in cell proliferationAngela Wu, Carina J Dumo, William H Cook, et al.
Molecular Therapy. Oncology|May 11, 2026
RNA-based precision medicine in glioblastoma driven by oncogenic gene fusionsMaël Bouillon, Clémentine Lapoujade, Laëtitia Basset, et al.
Molecular Therapy. Oncology|April 20, 2026
Engineered Salmonella-mediated c-di-AMP delivery activates STING to remodel the tumor microenvironmentYuanjia Huang, Linghua Piao, Haiwen Zhang, et al.
Molecular Therapy. Oncology|April 20, 2026
Mitochondrial inhibition enhances the sensitivity of pancreatic ductal adenocarcinoma cells to oncolytic adenovirusRyohei Shoji, Hiroshi Tazawa, Shinji Kuroda, et al.
Molecular Therapy. Oncology|April 20, 2026
AAV immuno-gene therapy platform delivering vectorized cytokines defines a new modality for high-grade glioma treatmentAkela Kuwahara, Ethan M Fenton, Chris Lovejoy, et al.
Molecular Therapy. Oncology|May 25, 2026
An integrative transcriptomic analysis for prognosis and tumor microenvironment in HBV/HCV-associated hepatocellular carcinomaFahimeh Safarnezhad Tameshkel, Niloufar Sadat Kalaki, Elham Karimi, et al.
Pageof 41